175 related articles for article (PubMed ID: 9829748)
1. DNA vaccination with HuD inhibits growth of a neuroblastoma in mice.
Carpentier AF; Rosenfeld MR; Delattre JY; Whalen RG; Posner JB; Dalmau J
Clin Cancer Res; 1998 Nov; 4(11):2819-24. PubMed ID: 9829748
[TBL] [Abstract][Full Text] [Related]
2. Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites.
Manley GT; Smitt PS; Dalmau J; Posner JB
Ann Neurol; 1995 Jul; 38(1):102-10. PubMed ID: 7541976
[TBL] [Abstract][Full Text] [Related]
3. DNA vaccination against HuD antigen elicits antitumor activity in a small-cell lung cancer murine model.
Ohwada A; Nagaoka I; Takahashi F; Tominaga S; Fukuchi Y
Am J Respir Cell Mol Biol; 1999 Jul; 21(1):37-43. PubMed ID: 10385591
[TBL] [Abstract][Full Text] [Related]
4. No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies.
de Beukelaar JW; Verjans GM; van Norden Y; Milikan JC; Kraan J; Hooijkaas H; Sintnicolaas K; Gratama JW; Sillevis Smitt PA
Cancer Immunol Immunother; 2007 Sep; 56(9):1501-6. PubMed ID: 17597332
[TBL] [Abstract][Full Text] [Related]
5. Neuron-specific hel-N1 and HuD as novel molecular markers of neuroblastoma: a correlation of HuD messenger RNA levels with favorable prognostic features.
Ball NS; King PH
Clin Cancer Res; 1997 Oct; 3(10):1859-65. PubMed ID: 9815574
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of the HuD gene encoding a paraneoplastic encephalomyelitis antigen in human lung cancer cell lines.
Sekido Y; Bader SA; Carbone DP; Johnson BE; Minna JD
Cancer Res; 1994 Sep; 54(18):4988-92. PubMed ID: 8069866
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic antibodies against HuD detected by a sensitive radiobinding assay.
Storstein A; Monstad SE; Nakkestad HL; Husebye ES; Vedeler CA
J Neurol; 2004 Feb; 251(2):197-203. PubMed ID: 14991355
[TBL] [Abstract][Full Text] [Related]
8. Induction of protective immune responses against NXS2 neuroblastoma challenge in mice by immunotherapy with GD2 mimotope vaccine and IL-15 and IL-21 gene delivery.
Kowalczyk A; Wierzbicki A; Gil M; Bambach B; Kaneko Y; Rokita H; Repasky E; Fenstermaker R; Brecher M; Ciesielski M; Kozbor D
Cancer Immunol Immunother; 2007 Sep; 56(9):1443-58. PubMed ID: 17597331
[TBL] [Abstract][Full Text] [Related]
9. A new small cell lung cancer (SCLC)-specific marker discovered through antigenic subtraction of neuroblastoma cells.
Krueger P; Nitz C; Foster R; MacDonald C; Gelber O; Lalehzadeh G; Goodson R; Winter J; Gelber C
Cancer Immunol Immunother; 2003 Jun; 52(6):367-77. PubMed ID: 12669243
[TBL] [Abstract][Full Text] [Related]
10. [The value of specific neuronal anti-Hu antibody in the early diagnosis of small cell lung cancer].
Wang G; Chen Q; Zhu Y; Ke D; Qian W; Song W
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Dec; 25(12):732-5. PubMed ID: 12622892
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral anti-HuD immunotoxin therapy for small cell lung cancer and neuroblastoma.
Ehrlich D; Wang B; Lu W; Dowling P; Yuan R
J Hematol Oncol; 2014 Dec; 7():91. PubMed ID: 25523825
[TBL] [Abstract][Full Text] [Related]
12. Hu antigen specificities of ANNA-I autoantibodies in paraneoplastic neurological disease.
King PH; Redden D; Palmgren JS; Nabors LB; Lennon VA
J Autoimmun; 1999 Dec; 13(4):435-43. PubMed ID: 10585760
[TBL] [Abstract][Full Text] [Related]
13. Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer.
Dalmau J; Graus F; Cheung NK; Rosenblum MK; Ho A; Cañete A; Delattre JY; Thompson SJ; Posner JB
Cancer; 1995 Jan; 75(1):99-109. PubMed ID: 7804984
[TBL] [Abstract][Full Text] [Related]
14. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.
Okada H; Attanucci J; Giezeman-Smits KM; Brissette-Storkus C; Fellows WK; Gambotto A; Pollack LF; Pogue-Geile K; Lotze MT; Bozik ME; Chambers WH
Cancer Res; 2001 Mar; 61(6):2625-31. PubMed ID: 11289140
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies against the Hel-N1 RNA-binding protein among patients with lung carcinoma: an association with type I anti-neuronal nuclear antibodies.
Dropcho EJ; King PH
Ann Neurol; 1994 Aug; 36(2):200-5. PubMed ID: 8053656
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
[TBL] [Abstract][Full Text] [Related]
17. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
Pan JP; Weng YS; Wu QQ
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
[TBL] [Abstract][Full Text] [Related]
18. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM
Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
20. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
Teramoto K; Kontani K; Ozaki Y; Sawai S; Tezuka N; Nagata T; Fujino S; Itoh Y; Taguchi O; Koide Y; Asai T; Ohkubo I; Ogasawara K
Cancer Res; 2003 Nov; 63(22):7920-5. PubMed ID: 14633722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
